161 related articles for article (PubMed ID: 19251804)
21. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
Bonfield TL; Farver CF; Barna BP; Malur A; Abraham S; Raychaudhuri B; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):677-82. PubMed ID: 12805087
[TBL] [Abstract][Full Text] [Related]
22. Cell sensitivity to oxidative stress is influenced by ferritin autophagy.
Kurz T; Gustafsson B; Brunk UT
Free Radic Biol Med; 2011 Jun; 50(11):1647-58. PubMed ID: 21419217
[TBL] [Abstract][Full Text] [Related]
23. IL-1α induces CD11b(low) alveolar macrophage proliferation and maturation during granuloma formation.
Huaux F; Lo Re S; Giordano G; Uwambayinema F; Devosse R; Yakoub Y; Panin N; Palmai-Pallag M; Rabolli V; Delos M; Marbaix E; Dauguet N; Couillin I; Ryffel B; Renauld JC; Lison D
J Pathol; 2015 Apr; 235(5):698-709. PubMed ID: 25421226
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary alveolar proteinosis: progress in the first 44 years.
Seymour JF; Presneill JJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):215-35. PubMed ID: 12119235
[TBL] [Abstract][Full Text] [Related]
26. [A case of pulmonary alveolar proteinosis with increased IgE and CEA].
Higuchi M; Kawarada Y; Nishio T; Takii M; Okubo H
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):255-60. PubMed ID: 8189647
[TBL] [Abstract][Full Text] [Related]
27. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
28. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages.
Simeonova PP; Luster MI
Am J Respir Cell Mol Biol; 1995 Jun; 12(6):676-83. PubMed ID: 7539275
[TBL] [Abstract][Full Text] [Related]
29. [A case of pulmonary alveolar proteinosis accompanied with the elevation of CEA (carcinoembryonic antigen) in bronchoalveolar lavage fluid].
Tanaka F; Nakamura M; Nakashima H; Suga M; Sugimoto M; Ando M; Araki S; Higuchi S
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):968-73. PubMed ID: 2615113
[TBL] [Abstract][Full Text] [Related]
30. [A case of pulmonary alveolar proteinosis with invasion of macrophages in alveolar interstitial region].
Ishida K; Hatakeyama S; Koumura K; Ebe T; Arai O
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Oct; 30(10):1852-7. PubMed ID: 1464988
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic bilateral lung lavage in a child with pulmonary alveolar proteinosis.
DiBlasi RM; Crotwell D; Geiduscheck JM; Richardson P; Smith A; Salyer JW; Rosenfeld M
Pediatr Crit Care Med; 2010 May; 11(3):e28-31. PubMed ID: 20453607
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary alveolar proteinosis.
Presneill JJ; Nakata K; Inoue Y; Seymour JF
Clin Chest Med; 2004 Sep; 25(3):593-613, viii. PubMed ID: 15331195
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary alveolar proteinosis in children.
de Blic J
Paediatr Respir Rev; 2004 Dec; 5(4):316-22. PubMed ID: 15531257
[TBL] [Abstract][Full Text] [Related]
34. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation.
Warheit DB; Hansen JF; Yuen IS; Kelly DP; Snajdr SI; Hartsky MA
Toxicol Appl Pharmacol; 1997 Jul; 145(1):10-22. PubMed ID: 9221819
[TBL] [Abstract][Full Text] [Related]
35. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary alveolar proteinosis: eleven-year follow-up in one case (author's transl)].
Jehan A; Borel B; Brun J; Boulier A; Leménager J
Poumon Coeur; 1982; 38(1):35-41. PubMed ID: 7088771
[TBL] [Abstract][Full Text] [Related]
37. Oxidant injury to the alveolar epithelium: biochemical and pharmacologic studies.
Freeman BA; Panus PC; Matalon S; Buckley BJ; Baker RR
Res Rep Health Eff Inst; 1993 Jan; (54):1-30; discussion 31-9. PubMed ID: 8439407
[TBL] [Abstract][Full Text] [Related]
38. Composition of bronchoalveolar lavage effluents from patients with pulmonary alveolar proteinosis.
Hook GE; Bell DY; Gilmore LB; Nadeau D; Reasor MJ; Talley FA
Lab Invest; 1978 Oct; 39(4):342-57. PubMed ID: 212641
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary alveolar proteinosis: a review.
deMello DE; Lin Z
Pediatr Pathol Mol Med; 2001; 20(5):413-32. PubMed ID: 11552740
[TBL] [Abstract][Full Text] [Related]
40. Rituximab therapy in autoimmune pulmonary alveolar proteinosis.
Borie R; Debray MP; Laine C; Aubier M; Crestani B
Eur Respir J; 2009 Jun; 33(6):1503-6. PubMed ID: 19483052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
